Cargando…
HSDL2 Promotes Bladder Cancer Growth In Vitro and In Vivo
Bladder cancer is a common malignant urinary tumor, and patients with bladder cancer have poor prognosis. Abnormal lipid metabolism in peroxisomes is involved in tumor progression. Hydroxysteroid dehydrogenase-like 2 (HSDL2) localized in peroxisomes regulates fatty acid synthesis. In the present stu...
Autores principales: | Jia, Ling-Hua, Hu, Mei-Di, Liu, Yuan, Xiong, Xing, Wang, Wei-Jia, Wang, Jin-Gen, Li, Qiu-Gen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566746/ https://www.ncbi.nlm.nih.gov/pubmed/31217732 http://dx.doi.org/10.7150/ijms.31288 |
Ejemplares similares
-
Down-regulated HSDL2 expression suppresses cell proliferation and promotes apoptosis in papillary thyroid carcinoma
por: Zeng, Jing, et al.
Publicado: (2019) -
HSDL2 Acts as a Promoter in Pancreatic Cancer by Regulating Cell Proliferation and Lipid Metabolism
por: Han, Anna, et al.
Publicado: (2021) -
Ectopic expression of HSDL2 is related to cell proliferation and prognosis in breast cancer
por: Dong, Bing, et al.
Publicado: (2019) -
Lentivirus-mediated overexpression of HSDL2 suppresses cell proliferation and induces apoptosis in cholangiocarcinoma
por: Zhang, Deng-Yong, et al.
Publicado: (2018) -
Role of Hydroxysteroid Dehydrogenase-Like 2 (HSDL2) in Human Ovarian Cancer
por: Sun, Qing, et al.
Publicado: (2018)